Drugs Xagena
The FDA released the following statement on the halting of a clinical trial of the Cox-2 inhibitor Celebrex ( celecoxib ): The Food and Drug Administration (FDA) learned from the National Cancer In ...
The FDA ( Food and Drug Administration ) announced important new information on side effects associated with the use of Bextra ( Valdecoxib ), a COX-2 selective non-steroidal anti-inflammatory drug ( ...
